Patent classifications
C
C12
C12N
2710/00
C12N2710/00011
C12N2710/24011
C12N2710/24041
C12N2710/24044
C12N2710/24044
Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene
The present invention provides vectors that contain and express in vivo or in vitro FeLV antigens that elicit an immune response in animal or human against FeLV, compositions comprising said vectors and/or FeLV polypeptides, methods of vaccination against FeLV, and kits for use with such methods and compositions.